LifeMD, Inc.
NASDAQ Global MarketTotal Valuation
LifeMD, Inc. carries a market capitalization of 160.16M, placing it among publicly traded companies globally. Its enterprise value stands at 1.10B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 160.16M |
| Enterprise Value | 1.10B |
Share Statistics
LifeMD, Inc. currently has 47.82M shares outstanding.
| Shares Outstanding | 47.82M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | 141.07 |
| P/TBV Ratio | -378.80 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, LifeMD, Inc. trades at an EV/EBITDA multiple of 167.57 and an EV/FCF ratio of 313.55.
| EV / Sales | 6.71 |
| EV / EBITDA | 167.57 |
| EV / EBIT | N/A |
| EV / FCF | 313.55 |
Financial Position
LifeMD, Inc. maintains a current ratio of 0.90, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 75.53, indicating elevated leverage, while an interest coverage ratio of -630.06 demonstrates limited ability to service its debt obligations.
| Current Ratio | 0.90 |
| Quick Ratio | 0.78 |
| Debt / Equity | 75.53 |
| Debt / EBITDA | -0.37 |
| Interest Coverage | -630.06 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | 0.30 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 7.36 |
Taxes
| Income Tax | 45,721.00 |
| Effective Tax Rate | N/A |
Stock Price Statistics
LifeMD, Inc.'s stock has gained approximately 0.54580479% over the past 52 weeks. The 50-day moving average sits at 23.36, while the 200-day moving average is 23.12.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0.54580479% |
| 50-Day Moving Average | 23.36 |
| 200-Day Moving Average | 23.12 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -16.38M, while operating income came in at -24.25M.
| Revenue | 164.70M |
| Gross Profit | 141.85M |
| Operating Income | -24.25M |
| Pretax Income | -25.38M |
| Net Income | 201,011.00 |
| EBITDA | -16.38M |
| EBIT | -24.25M |
| Earnings Per Share (EPS) | N/A |
Balance Sheet
LifeMD, Inc. holds 25.14M in cash and equivalents against 6.02M in total debt, resulting in a net debt position of -25.14M. Total book value stands at 7.97M, with working capital of -4.52M providing operational flexibility.
| Cash & Cash Equivalents | 25.14M |
| Total Debt | 6.02M |
| Net Debt | -25.14M |
| Equity (Book Value) | 7.97M |
| Book Value Per Share | 0.17 |
| Working Capital | -4.52M |
Cash Flow
LifeMD, Inc. produced -9.91M in operating cash flow over the past twelve months.
| Operating Cash Flow | -9.91M |
| Capital Expenditures | -1.15M |
| Free Cash Flow | -11.06M |
| FCF Per Share | N/A |
Margins
LifeMD, Inc. operates with a gross margin of 86.13, reflecting its pricing power and cost economics. The operating margin of -14.72 and net profit margin of 0.12 provide insight into operational efficiency.
| Gross Margin | 86.13 |
| Operating Margin | -14.72 |
| Pretax Margin | -15.41 |
| Profit Margin | 0.12 |
| EBITDA Margin | -9.95 |
Dividends & Yields
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Shareholder Yield | 0.98 |
| FCF Yield | N/A |
Scores
LifeMD, Inc. posts an Altman Z-Score of 7.57, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 7.57 |